Noxiptiline

Noxiptiline

Noxiptiline (Agedal, Elronon, Nogedal), also known as noxiptyline and dibenzoxine, is a tricyclic antidepressant (TCA) that was introduced in Europe in the 1970s for the treatment of depression.[1][2][3] It has imipramine-like effects,[4] acting as a serotonin and norepinephrine reuptake inhibitor, among other properties.[5][6] Of the TCAs, noxiptiline has been shown to be one of the most effective, rivaling amitriptyline in clinical efficacy.[7][8]

See also

References